
Relapsed or refractory mediastinal B-cell lymphoma Program in Pharmaceutical Benefits Scheme (PBS) 012-20082617

[Expand/Collapse all sections]Expand all

-   Background
-   Process
-   Resources

Relapsed or refractory mediastinal B-cell lymphoma restriction and item codes

Do not share this attachment externally. See Freedom of Information –
Information Publication Scheme.

[] Relapsed or refractory mediastinal B-cell lymphoma - pembrolizumab
restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

Relapsed or refractory Mediastinal B-cell lymphoma - pembrolizumab
initial PBS Authority application form (PB296)

Services Australia website links

Relapsed or refractory mediastinal B-cell lymphoma

External websites

PBS schedule for Relapsed or refractory mediastinal B-cell lymphoma

                                   

-   Services Australia ABN 90 794 605 008 
